Thermo Fisher Scientific (TMO) recently introduced the Applied Biosystems Axiom BloodGenomiX Array and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects most extended and rare blood groups, tissue (HLA) and platelet (HPA) types in a single, highthroughput assay, supporting future advancements in donor blood matching for extended phenotypes. The latest development is expected to enhance the company's Life Sciences Solutions segment, which off ...